Louisiana AI Medical Transcription Disclosure

Overview

Louisiana House Bill 475 (HB 475) of the 2026 Regular Session was enacted into law as Act No. 649 and took effect on August 1, 2026. The Act amends Louisiana Revised Statutes by adding R.S. 37:22.1, regulating the use of artificial intelligence in healthcare documentation across the state. While the bill initially proposed requiring explicit patient consent before recording visits for AI transcription, legislative amendments shifted the mandate to verbal disclosure. Healthcare professionals in Louisiana must verbally inform patients prior to recording any part of an appointment or treatment that will be transcribed using artificial intelligence.

Definitions

Within the context of Louisiana HB 475, several key terms are implicitly or explicitly defined to ensure clarity and consistent application of the law. A 'healthcare professional' refers to any individual licensed under Title 37 of the Louisiana Revised Statutes, encompassing a wide array of medical practitioners who provide appointments or treatments to patients. This broad definition ensures that the disclosure requirements apply across various healthcare settings and specialties, from physicians and nurses to therapists and other allied health professionals. The term 'patient' refers to any individual receiving care or treatment from a healthcare professional, whose communications during an appointment or treatment may be subject to AI transcription. This establishes the scope of individuals whose data and privacy are protected under the bill's provisions, emphasizing the patient-centric nature of the regulation.

Furthermore, the legislation focuses on the 'use of a recording device, software, or service to transcribe using artificial intelligence.' This phrase is central to the bill's intent. A 'recording device' could include any electronic apparatus capable of capturing audio, such as a digital recorder, a smartphone, or an integrated system within an electronic health record (EHR) platform. 'Software' or 'service' refers to the specific artificial intelligence applications or platforms that process the recorded audio to convert spoken language into written text. The critical element here is the 'artificial intelligence' component, which distinguishes these transcription methods from traditional human transcription services. While the bill itself does not delve into a technical definition of AI, it implicitly refers to systems that employ machine learning, natural language processing, or similar advanced algorithms to perform transcription tasks. The act of 'transcribing' involves the conversion of spoken words from a medical consultation into a written format, typically for inclusion in a patient's medical record. These definitions collectively delineate the specific activities and actors subject to the disclosure requirements, ensuring that the law targets the intended technological applications in healthcare.

Governance and Institutional Framework

The governance and institutional framework for Louisiana HB 475 will primarily involve existing state agencies and professional licensing boards responsible for overseeing healthcare professionals. While the bill itself does not establish a new regulatory body, its implementation and enforcement will likely fall under the purview of entities such as the Louisiana Department of Health (LDH) and various professional licensing boards, including the Louisiana State Board of Medical Examiners, the Louisiana State Board of Nursing, and other boards governing specific healthcare professions. These bodies are already tasked with regulating the conduct of licensed professionals, ensuring adherence to ethical standards, and enforcing state laws pertaining to healthcare practice. Consequently, non-compliance with the AI transcription disclosure requirement would likely be treated as a violation of professional conduct, subject to the disciplinary processes of the relevant licensing board. This approach leverages established regulatory mechanisms, avoiding the creation of redundant bureaucratic structures and integrating AI-related compliance into existing oversight frameworks.

The role of these existing institutions will extend to developing any necessary interpretive guidance or administrative rules to clarify the practical application of HB 475. For instance, licensing boards may issue advisories on what constitutes adequate disclosure, how records of disclosure should be maintained, and the specific circumstances under which the law applies. The Louisiana Department of Health might also play a role in broader public awareness campaigns or in coordinating with healthcare facilities to ensure widespread understanding and adoption of the new requirements. Furthermore, patient advocacy groups and professional associations within Louisiana healthcare are likely to contribute to the informal governance landscape by educating their members and the public, promoting best practices, and potentially advocating for further refinements to the regulatory framework as AI technology continues to evolve. This distributed governance model relies on the established expertise and enforcement capabilities of existing state-level healthcare regulators to uphold the transparency objectives of HB 475.

Key Focus Areas

The central focus of Louisiana HB 475, in its adopted form, is the mandatory disclosure by healthcare professionals to patients regarding the use of artificial intelligence for transcribing medical appointments or treatments. This requirement is a direct response to the increasing deployment of AI-powered tools in clinical settings, which can record and process sensitive patient-provider communications. The bill stipulates that a healthcare professional must inform a patient, prior to the commencement of an appointment or treatment, if any recording device, software, or service utilizing AI will be employed for transcription. This ensures that patients are made aware of the technological means by which their conversations are being documented, addressing concerns about informational privacy and the processing of their verbal data. The emphasis on pre-appointment disclosure is critical, as it provides patients with timely information before any recording or AI transcription begins, allowing them to proceed with full knowledge of the process.

Crucially, the bill's amendments during the legislative process removed the initial provisions that would have required explicit patient consent and offered an opt-out mechanism for AI transcription. This shift means that while healthcare professionals must disclose the use of AI transcription, they are not legally obligated to obtain explicit verbal or written consent from the patient for this specific purpose, nor are patients granted a statutory right to refuse the use of AI transcription for their medical visit under this particular bill. This distinction is vital for understanding the scope and limitations of HB 475. The law prioritizes transparency and patient awareness over patient control in this specific context. The implications are that healthcare providers can implement AI transcription services, provided they fulfill their disclosure obligation, without needing to navigate individual patient consent for the AI component itself. This streamlined approach aims to facilitate the adoption of beneficial AI technologies while still upholding a fundamental level of patient informational autonomy through clear communication.

Implementation Framework

The implementation framework for Louisiana HB 475 will necessitate practical adjustments by healthcare professionals and facilities across the state. Healthcare providers will need to establish clear and consistent procedures for informing patients about the use of AI transcription services. This could involve various methods, such as prominent signage in waiting areas, verbal announcements at the beginning of an appointment, or written notices included in patient intake forms or pre-visit communications. The key is that the disclosure must occur 'prior to an appointment or treatment', ensuring patients have this information upfront. For larger healthcare systems, this might entail updating existing privacy policies and training staff on the new disclosure requirements. Smaller practices may need to develop new protocols to ensure compliance, potentially utilizing standardized forms or scripts for informing patients. The goal is to integrate the disclosure seamlessly into the patient care workflow without causing undue disruption, while still effectively communicating the necessary information.

Furthermore, healthcare organizations will need to consider how to document these disclosures. While the bill does not explicitly mandate a specific method for recording that disclosure was made, best practices in healthcare compliance often suggest maintaining a record to demonstrate adherence to regulatory requirements. This could involve a simple check-box on an intake form, a notation in the patient's electronic health record (EHR), or a standardized verbal script that is acknowledged by the patient. The choice of method will likely depend on the size and resources of the healthcare provider, but the underlying principle remains the same: proving that the patient was informed. The bill's addition of R.S. 37:22.1 into Louisiana law signifies a new legal obligation, and healthcare providers will be expected to demonstrate due diligence in meeting this requirement. This framework emphasizes proactive communication and robust internal processes to ensure that the spirit of transparency intended by HB 475 is upheld in daily clinical practice, thereby fostering patient trust and mitigating potential misunderstandings about AI's role in their medical documentation.

Monitoring and Evaluation

Monitoring and evaluation of Louisiana HB 475 will primarily rely on a combination of patient feedback mechanisms and the oversight functions of state professional licensing boards. Patients who believe a healthcare professional has failed to disclose the use of AI transcription as required by law will likely have avenues to file complaints with the relevant licensing board (e.g., medical, nursing, or other professional boards). These boards, in turn, would be responsible for investigating such complaints, determining if a violation occurred, and imposing appropriate disciplinary actions if necessary. This complaint-driven monitoring system places a degree of responsibility on patients to report non-compliance, while empowering the established regulatory bodies to enforce the law. Additionally, professional associations may play an informal monitoring role by disseminating information, offering training, and encouraging their members to adhere to the new disclosure standards, thereby promoting a culture of compliance within the healthcare community.

Over time, the effectiveness of HB 475 could be evaluated through various metrics. Licensing boards might track the number and nature of complaints related to AI transcription disclosure, providing data on areas of potential non-compliance or confusion. The Louisiana Department of Health, or other state agencies, could conduct surveys or studies to assess patient awareness levels regarding AI use in healthcare and their perceptions of the disclosure process. Furthermore, as AI technology evolves, the state legislature may revisit HB 475 to determine if the current disclosure-only framework remains adequate or if further amendments, such as explicit consent or more detailed regulatory guidance, are warranted. This ongoing evaluation process is crucial for ensuring that the legislation remains relevant and effective in addressing the dynamic landscape of AI in healthcare, adapting to new technological capabilities and emerging patient concerns. The initial implementation will serve as a foundational step, with future adjustments informed by practical experience and continuous assessment of the law's impact on patient transparency and professional practice.

Penalties, Liability, and Appeals

Under R.S. 37:22.1(B), enforcement of the AI transcription disclosure requirement is delegated to state professional licensing boards. A healthcare professional who fails to verbally disclose the use of AI recording or transcription tools may face administrative disciplinary action by their respective licensing board. Furthermore, the Act explicitly grants civil immunity to healthcare professionals for disclosure violations, except in cases involving gross negligence or willful misconduct, thereby precluding private civil lawsuits for simple disclosure omissions.

Relationship to Other Instruments

Louisiana HB 475 operates within a complex web of existing legal instruments governing healthcare, privacy, and professional conduct. Most notably, it complements and interacts with existing state laws related to patient rights and medical record confidentiality. While HB 475 specifically addresses the disclosure of AI transcription, it does not supersede or diminish other state statutes that protect patient privacy, govern the handling of sensitive health information, or define the scope of informed consent for medical procedures. For instance, Louisiana's general laws concerning patient confidentiality and the integrity of medical records would still apply to the data generated through AI transcription, requiring healthcare providers to maintain the same standards of security and privacy for AI-generated notes as they would for any other part of a patient's medical file. The bill effectively adds a layer of transparency regarding the method of documentation without altering the fundamental protections afforded to the content of that documentation.

Furthermore, the bill's requirements are designed to integrate with the existing ethical guidelines and professional standards set by various healthcare licensing boards in Louisiana. These boards often have broad mandates to ensure that licensed professionals act in the best interest of their patients, maintain professional integrity, and uphold ethical practices. The disclosure requirement of HB 475 can be seen as an extension of these existing ethical obligations, promoting honesty and transparency in the patient-provider relationship. While the bill does not directly amend or reference these broader ethical codes, its provisions will undoubtedly influence how professional conduct is interpreted and enforced in the context of AI use. The legislation also contributes to the growing body of state-level statutes addressing technology in healthcare, signaling Louisiana's intent to keep its legal framework current with technological advancements. By adding a specific provision (R.S. 37:22.1) to the Revised Statutes, HB 475 carves out a distinct, yet interconnected, space within Louisiana's comprehensive legal framework for healthcare.

National/Federal Alignment

Louisiana HB 475 aligns with broader national and federal discussions surrounding artificial intelligence, data privacy, and healthcare technology, particularly concerning patient rights and transparency. While the bill is a state-level initiative, its principles resonate with federal regulations such as the Health Insurance Portability and Accountability Act (HIPAA). HIPAA establishes national standards for protecting sensitive patient health information, and while it doesn't specifically address AI transcription disclosure, the spirit of patient privacy and control over health data is a core tenet. HB 475 enhances patient awareness regarding the collection method of their health information, thereby indirectly supporting the broader goals of HIPAA by promoting transparency in data handling practices within a specific technological context. Federal agencies, including the Department of Health and Human Services (HHS), have also increasingly emphasized the responsible development and deployment of AI in healthcare, often highlighting the need for transparency and ethical considerations.

Moreover, HB 475 contributes to a patchwork of state-level AI regulations emerging across the United States. As there is currently no comprehensive federal law specifically governing AI, states are taking the lead in addressing particular applications and concerns. Louisiana's focus on AI in medical transcription reflects a common area of concern—the intersection of advanced technology with sensitive personal data and professional services. This state-level action can inform future federal policy debates, providing practical examples of regulatory approaches and their impacts. While HB 475 does not impose conflicting requirements with federal law, it adds a specific layer of state-mandated transparency that complements existing federal privacy protections. The bill's existence underscores the growing recognition at both state and federal levels that AI, particularly in high-stakes sectors like healthcare, requires careful consideration to ensure patient trust, data security, and ethical deployment, contributing to a broader national dialogue on responsible AI governance.

Implementation Timeline

The legislative and implementation milestones for HB 475 (Act No. 649) are as follows: Introduced on February 27, 2026; Reported with amendments by House Committee on Health and Welfare on April 3, 2026; Passed House on April 14, 2026; Passed Senate with floor amendments on May 18, 2026; House concurred in Senate amendments on May 26, 2026; Enrolled and sent to Governor on May 28, 2026; Signed by Governor as Act No. 649 on June 2, 2026; Entered into force on August 1, 2026.

Sources and References